Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.
about
Extended-spectrum beta-lactamases: a clinical updatePseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital.Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon.Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa.Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosaComplex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene.Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactamsPseudomonas aeruginosa: resistance to the maxAmbler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impactDevelopment of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationDistribution and Classification of Serine β-Lactamases in Brazilian Hospital Sewage and Other Environmental Metagenomes Deposited in Public Databases.OXA β-lactamases.Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century.The extended-spectrum AmpC genotype of Pseudomonas aeruginosa strains from Egypt: an underlying threat to anti-pseudomonal treatment options.Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary.Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India.Distribution of the bla OXA , bla VEB-1 , and bla GES-1 genes and resistance patterns of ESBL-producing Pseudomonas aeruginosa isolated from hospitals in Tehran and Qazvin, Iran.Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosaStructure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell cultureDifferential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiproleSCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.Increased frequency of integrons and β-lactamase-coding genes among extraintestinal Escherichia coli isolated with a 7-year interval.Integron-bearing Gram-negative bacteria in lake waters.Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.
P2860
Q24534999-8F20FFF2-D2D3-4D5F-9201-69FC615E96A5Q33236778-A6BBA67B-AA01-46BA-BD68-0DF9B72FEFE7Q33967629-A0B85616-12FC-4D49-BA47-43A5F2181700Q34058227-0282D36C-4781-4A92-98E0-6F4D06194BFBQ34139754-423B46CA-F80C-4FA1-BBC3-526AF05D0C99Q34555131-CB4CEC2E-2CD7-4F3F-B72B-0C33F6947AABQ34587259-949FA438-B6FD-4BEF-8DF8-76CE8C5C1B55Q34648772-39A26341-B204-4944-ACEB-7F648B85FF85Q34942268-3D90E535-47C4-4D55-977F-71D7424A454EQ35084559-EEC4A7DA-B415-44DA-BF0D-3A2E4DE22676Q35183983-84014B10-BCEA-4C8A-BCB6-853038E16813Q36095041-B6DFC23F-D225-4374-8930-7A03F9B37A43Q36098603-75E314F0-E756-40B7-9D61-B8F83E2E0AABQ36295397-3A604457-71CF-467A-AF15-D116A0E3ED50Q37413711-FF89B250-AF7A-42CA-A391-FFF4963366FBQ38201699-6923CB4F-B0E6-4376-971E-010BFD3ACE04Q38544980-F77B7CAC-1254-4312-B272-87DEAB27B2C2Q38988534-1DA1333C-7CAB-4BDF-B2D2-E607363B3CA4Q39245554-18B7ED98-83A7-4C4D-9315-F59371D063ADQ39954478-25086403-0C56-43BB-9969-312EC6197EDFQ40138355-999B7821-8EB8-4C00-AE41-11A429979338Q41827007-758E12C3-28E3-46F9-8ABD-3AB244FC7678Q41874068-DD94F529-1462-4001-8FFD-029E0AA86A30Q42089045-ED19A0CB-B0A1-4A15-A164-95BF11DE6C05Q42184834-A3C8EB3D-D45C-4D4D-B5CB-6C606E9F7FF3Q42426450-C73951F4-B84D-4D1B-B213-A0E463395E32Q43167978-D7D1DDDA-DC4B-4A12-8C21-A05BE2D38114Q44222331-B097E3A8-214C-48B7-B5E2-FDF75CFA53AD
P2860
Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prospective survey of beta-lac ...... in a French hospital in 2000.
@ast
Prospective survey of beta-lac ...... in a French hospital in 2000.
@en
Prospective survey of beta-lac ...... in a French hospital in 2000.
@nl
type
label
Prospective survey of beta-lac ...... in a French hospital in 2000.
@ast
Prospective survey of beta-lac ...... in a French hospital in 2000.
@en
Prospective survey of beta-lac ...... in a French hospital in 2000.
@nl
prefLabel
Prospective survey of beta-lac ...... in a French hospital in 2000.
@ast
Prospective survey of beta-lac ...... in a French hospital in 2000.
@en
Prospective survey of beta-lac ...... in a French hospital in 2000.
@nl
P2093
P2860
P1476
Prospective survey of beta-lac ...... in a French hospital in 2000.
@en
P2093
Catherine Chanal
Christophe De Champs
Danielle Sirot
Jacques Sirot
Richard Bonnet
P2860
P304
P356
10.1128/AAC.46.9.3031-3034.2002
P407
P577
2002-09-01T00:00:00Z